Medical Treatment of Peptic Ulcer Disease

Publisher Website
Google Scholar
Abstract
Objective. —To integrate the realization that peptic ulcer most commonly reflects infection withHelicobacter pylorior use of aspirin and other nonsteroidal antiinflammatory drugs (NSAIDs) into a disease management approach. Participants. —Guidelines were outlined by the author and presented for review to the American College of Gastroenterology (ACG) Practice Parameters Committee, selected by the president of the ACG, and a panel of experts in peptic ulcer, selected by the committee. Evidence and Consensus Process. —These guidelines were formulated following extensive review of the literature obtained by a MEDLINE search and presented for detailed review and revision to unpublicized committee meetings on three occasions and to experts by mail. These recommendations are an official statement of the ACG and have been approved by the American Gastroenterological Association and the American Society for Gastroenterological Endoscopy. Firm recommendations are discriminated from reasonable suppositions pending definitive data. Conclusions. —Since cure ofH pyloriinfection decreases recurrence rates and facilitates healing, antibiotic therapy is indicated for allH pylori—infected ulcer patients. No optimal, simple antibiotic regimen has yet emerged. Simultaneous conventional ulcer therapy is recommended to facilitate symptom relief and healing. For refractory ulcers, only maximal acid inhibition offers advantage over continued conventional therapy; cure ofH pyloriinfection is likely to facilitate healing of refractory ulcers. Only with complicated or refractory ulcers should conventional maintenance therapy be continued, at least until successfulH pylorieradication is confirmed. A search for NSAID use is indicated for all ulcer patients. For NSAIDassociated ulcers these drugs should be discontinued if possible andH pylori, if present, should be cured. (JAMA. 1996;275:622-629)

This publication has 1 reference indexed in Scilit: